Kissei Pharmaceutical Co., Ltd. (KSPHF)

Kissei Pharmaceutical Revenue

Kissei Pharmaceutical had revenue of 22.19B JPY in the quarter ending June 30, 2025, with 4.85% growth. This brings the company's revenue in the last twelve months to 89.36B, up 15.40% year-over-year. In the fiscal year ending March 31, 2025, Kissei Pharmaceutical had annual revenue of 88.33B with 16.87% growth.

• Revenue (ttm): 89.36B JPY
• Revenue Growth: +15.40%
• P/S Ratio: 1.96
• Revenue / Employee: 50.26M JPY
• Employees: 1,778
• Market Cap: 1.21B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	88.33B	12.75B	16.87%
Mar 31, 2024	75.58B	8.09B	11.98%
Mar 31, 2023	67.49B	2.11B	3.23%
Mar 31, 2022	65.38B	-3.66B	-5.31%
Mar 31, 2021	69.04B	5.81B	9.19%